Vector Insert-Targeted Integrative Antisense Expression System for Plasmid Stabilization
- 187 Downloads
Some DNA vaccine and gene therapy vector-encoded transgenes are toxic to the E. coli plasmid production host resulting in poor production yields. For plasmid products undergoing clinical evaluation, sequence modification to eliminate toxicity is undesirable because an altered vector is a new chemical entity. We hypothesized that: (1) insert-encoded toxicity is mediated by unintended expression of a toxic insert-encoded protein from spurious bacterial promoters; and (2) that toxicity could be eliminated with antisense RNA-mediated translation inhibition. We developed the pINT PR PL vector, a chromosomally integrable RNA expression vector, and utilized it to express insert-complementary (anti-insert) RNA from a single defined site in the bacterial chromosome. Anti-insert RNA eliminated leaky fluorescent protein expression from a target plasmid. A toxic retroviral gag pol helper plasmid produced in a gag pol anti-insert strain had fourfold improved plasmid fermentation yields. Plasmid fermentation yields were also fourfold improved when a DNA vaccine plasmid containing a toxic Influenza serotype H1 hemagglutinin transgene was grown in an H1 sense strand anti-insert production strain, suggesting that in this case toxicity was mediated by an antisense alternative reading frame-encoded peptide. This anti-insert chromosomal RNA expression technology is a general approach to improve production yields with plasmid-based vectors that encode toxic transgenes, or toxic alternative frame peptides.
KeywordsPlasmid DNA vaccine Antisense RNA Non-viral vector Vector stabilization Strain engineering
We thank Sheryl Anderson and Angela Schukar for cleaning, batching, and operating fermentors. This article described work that was supported by the National Institute of Health [R44GM072141 and R43GM073394 to J.A.W.].
Conflicts of Interest Statement
JML, AEC, CPH and JAW have an equity interest in Nature Technology Corporation.
- 4.Engels, P., & Meyer, P. (1993). Inactivation of the transcriptional-dependent inhibition of plasmid replication: a selection method for cloning large DNA fragments. Biotechniques, 14, 324–325.Google Scholar
- 9.Weiner, D. B., Zhang, D., & Cohen, A. (2005). Expression system for cloning toxic genes. United States Patent 6881558.Google Scholar
- 11.Boyd, A. C., Popp, F., Michaelis, U., Davidson, H., Davidson-Smith, H., Doherty, A., et al. (1999). Insertion of natural intron 6a–6b into a human cDNA-derived gene therapy vector for cystic fibrosis improves plasmid stability and permits facile RNA/DNA discrimination. Journal of Gene Medicine, 1, 312–321.CrossRefGoogle Scholar
- 15.Williams, J. A. (2008). Vectors and methods for genetic immunization. WO 2008/153733.Google Scholar
- 20.Makrides, S. C. (1996). Strategies for achieving high-level expression of genes in Escherichia coli. Microbiological Reviews, 60, 512–538.Google Scholar